ODAN-CYCLOPENTOLATE DIN 00626635
Health Canada record
| Active ingredient(s) | CYCLOPENTOLATE HYDROCHLORIDE 0.5 % |
|---|---|
| Dosage form | Solution |
| Route | Ophthalmic |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | S01FA04 CYCLOPENTOLATE |
| Original market date | 31-Dec-1984 |
| Current status date | 22-Jun-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Odan Laboratories Ltd. — licence 100025, currently licensed, last inspection rating C (2024-03-12).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CYCLOPENTOLATE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00252506 | CYCLOGYL | ALCON CANADA INC | Drops | CYCLOPENTOLATE HYDROCHLORIDE 1 % | Marketed |
| 02148382 | MINIMS CYCLOPENTOLATE HYDROCHLORIDE | BAUSCH & LOMB INC | Solution | CYCLOPENTOLATE HYDROCHLORIDE 1 % | Marketed |
| 00626627 | ODAN-CYCLOPENTOLATE | ODAN LABORATORIESLTD | Solution | CYCLOPENTOLATE HYDROCHLORIDE 1 % | Marketed |
| 02023687 | CYCLOPENTOLATE | PHARMA STULLN INC. | Solution | CYCLOPENTOLATE HYDROCHLORIDE 0.5 % | Cancelled Post Market |
| 02023644 | CYCLOPENTOLATE | PHARMA STULLN INC. | Solution | CYCLOPENTOLATE HYDROCHLORIDE 1 % | Cancelled Post Market |
| 02181436 | DOM-CYCLOPENTOLATE HCL OPHTHALMIC SOLUTION-1% | DOMINION PHARMACAL | Solution | CYCLOPENTOLATE HYDROCHLORIDE 1 % | Cancelled Post Market |
| 02148331 | MINIMS CYCLOPENTOLATE HYDROCHLORIDE | BAUSCH & LOMB INC | Solution | CYCLOPENTOLATE HYDROCHLORIDE 0.5 % | Dormant |
| 00878189 | PMS-CYCLOPENTOLATE HCL OPH SOLUTION 1% | PHARMASCIENCE INC | Liquid | CYCLOPENTOLATE HYDROCHLORIDE 1 % | Cancelled Post Market |
International API supply for CYCLOPENTOLATE HYDROCHLORIDE
2 valid EDQM Certificates of Suitability from 2 holders. 2 active FDA Drug Master Files.
Request a quote for ODAN-CYCLOPENTOLATE